KCNQ1, identified as an ERS-associated biomarker in IDD, impacts the Notch signaling pathway and immune cell infiltration, suggesting its potential as a therapeutic target for IDD. This evidence concerns the gene KCNQ1 and intervertebral disk degenerative disorder.